Fast and reliable diagnostics of SARS-CoV-2 is one of the most important preventing measures to stop COVID-19. As no vaccine or treatment currently exist, isolation of people together with diagnosing COVID-19 help to spare lives and ease the burden of healthcare systems.
GenomEra SARS-CoV-2 is a rapid multiplex RT-PCR test for the detection of RdRp and E genes. RNA extraction is not needed, which dramatically reduces the time and workload of the laboratory personnel. Results are automatically and reliably reported by GenomEra software.
The sample preparation is simple and requiring only one quick heating step. GenomEra Test Chips contain all the reagents needed for RT-PCR, which enables performing the testing in laboratories without any earlier experience of PCR.
• Four results in 70 minutes as no RNA extraction is needed
• RT-PCR detection of RdRp and E genes
• The same sample can be used for both SARS-CoV-2 and Flu A/B+ RSV tests
• Any kind of laboratory can adapt GenomEra testing
NOTE! GenomEra RUO SARS-CoV-2 test has a special approval in Finland and is available for research use in other countries.